PATENT CLAIM ANALYSIS

Application Number: 15949509
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["435", "325000"]

Abstract:
The present invention relates to the use of an hydrogel comprising silylated biomolecule for the three-dimensional culture of cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and to an aqueous composition comprising i) cardiomyocytes or stem cells which are able to differentiate into cardiomyocytes, and ii) a hydrogel comprising silylated biomolecule, for use for treating heart failure, in particular heart failure following myocardial infarction.

Claim (Index 23):
The method according to  claim 21 , wherein the hydrogel solution (ii) has the following rheological characteristics at a pH value of 7.4 (after 3 weeks of reticulation):\n a compressive modulus at 5% stress from 220 to 430 Pa; a storage modulus (G\u2032) from 235 to 450 Pa; a loss modulus (G\u2033) from 29 to 60 Pa; a gel point from 23.8 to 30.6 minutes.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.7619
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14123286', '13777139', '12751445', '14127991', '14473521']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6266734353952383
- 35 USC 102 Novelty (BERT): 0.6391246728843526
- Combined Prediction Score: 0.6279185591441497
- Mean Citation Score: 309.78278199999994
- Max Citation Score: 614.4156
- Similarity Product: 570.7053471311331

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test